Patent application number | Description | Published |
20080214542 | Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands - The invention concerns compounds of general formula (I), a method for preparing same, as well as their use as therapeutic agent. | 09-04-2008 |
20090111808 | NOVEL HISTAMINE H3-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS - The present patent application concerns compounds of formula (I) with R1 and R2 taken together with the nitrogen atom to which they are attached, form a mono or bicyclic saturated nitrogen-containing ring; their preparation and their use as a H3 receptor ligand for treating e.g. CNS disorders like Alzheimer's disease. | 04-30-2009 |
20090264469 | NOVEL DICARBOXYLIC ACID DERIVATIVES - The present patent application concerns new compounds of formula (I): displaying agonistic activity at sphingosine-1-phosphate (S1P) receptors, their process of preparation and their use as immunosuppressive agents. | 10-22-2009 |
20090286801 | CARBONYLATED (AZA) CYCLOHEXANES AS DOPAMINE D3 RECEPTOR LIGANDS - The invention relates to compounds of the general formula (I): to the process for preparing them, and to the use thereof as a therapeutic agent. | 11-19-2009 |
20100249187 | NOVEL DICARBOXYLIC ACID DERIVATIVES AS S1P1 RECEPTOR AGONISTS - The present invention relates to new compounds of formula (I) possessing agonistic activity at sphingosine-1-phosphate (S1P) receptors, their process of preparation and their use as immunosuppressive agents. The invention is also directed to pharmaceutical compositions containing these compounds and use of these compounds for treatment/prevention of immune mediated diseases and conditions or inflammatory diseases and conditions. | 09-30-2010 |
20130231329 | Benzazole Derivatives as Histamine H4 Receptor Ligands - The present patent application concerns new ligands of the H4-receptor of formula (I), their process of preparation and their therapeutic use. | 09-05-2013 |